Neoprobe names new chief development officer

11/18/2010 | MedCityNews.com

Neoprobe has designated Mark Pykett as its new chief development officer. Pykett was the founder of Talaris Advisors and was chief operating officer at Alseres Pharmaceuticals. Pykett will help the company in securing approval for its tracing agent Lymphoseek, as well as determine a collaborating firm for RIGScan, another tracing agent still in early development stages.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Group Health Cooperative
Group Health Cooperative
Seattle, WA
Systems Test - V&V Engineer - 14000008LS
Abbott
San Jose, CA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)